InnoUp patented technology consists on a new encapsulation platform based on biocompatible nanoparticles with high bioadhesive capacity, which allows them to stay more time in contact with the intestinal wall and therefore a sustained release of the content occurs.
These bioadhesive nanoparticles can be used to achieve several objectives:
Briefly, the uniqueness of this innovative system allows:
More selective and effective and therefore less toxic drugs.
Easier and cheaper to administer drugs (i.e. oral, nasal, pulmonary routes)
New drugs or therapies that would be feasible only into a nanosystem that solubilizes or protect them from degradation
Controlled Release Drug